The EZ-HT Experiment

Most infants under five months are protected from measles by maternal antibodies, and standard measles vaccines are ineffective in babies under nine months. Since measles death rates are higher in Third World countries, authorities decided to create a “high-titer” vaccine to target this 5-9 month age range.

Beginning in the 1980s, they tested the Edmonston-Zagreb (EZ-HT) strain on Mexican and Gambian babies 4-6 months old.

The same high-titer vaccine continued to be administered in Guinea-Bissau, Togo, Senegal, Bangladesh, Haiti, and impoverished minority communities in Los Angeles, California.

The public was told that EZ-HT “produces a better immunological response than standard vaccines,” but studies had been conducted that concluded the vaccine was unsafe for infants, including the following: Child mortality after high-titre measles vaccines: prospective study in Senegal.

The study concluded, quite unequivocally, that “The higher risk of death in the two high-titre vaccine groups remained significant in multivariate analyses. These findings suggest a need to reconsider the use of high-titre measles vaccines early in life in less developed countries.”

From 1987 to 1989, scientists set up a research center near 30 remote villages in central Senegal. Their stated primary objective was to study the clinical efficacy of two high-titer measles vaccines: Edmonston-Zagreb (EZ-HT) and Schwartz (SW-HT).

Researchers may have suspected the vaccine was dangerous when the results of earlier studies began to filter in. But they were probably reluctant to abandon their high-titer shot without testing it at least one more time to be sure. Senegal must have seemed ideal; the region was extremely remote, and less than 4% of the mothers who “consented” to the study were literate.

When the results were tabulated (using eight statistical procedures) it became clear that children who received the high-titer measles vaccines had significantly higher mortality rates at 41 months than children in the standard low-titer measles vaccine group.

But they were not dying from measles. Most of the deaths were from other common childhood diseases. Apparently, the high-titer measles vaccines lowered overall immunity making the children fatally susceptible to diarrhea, dysentery, malaria, malnutrition, acute respiratory ailments, and other infectious diseases.

 

Babies who received SW-HT died at a rate that was 51% higher than those who received the standard vaccine...nearly 50 excess deaths for every 1000 babies vaccinated. EZ-HT was much more potent, contributing to a rate that was 80% higher, contributing to 75 excess deaths for every 1000.

Strikingly, according to the previously cited study published by Lancet in 1991, 1 in every 6 babies vaccinated with EZ-HT died within three years. Unfortunately, even this didn't deter enthusiasts of the high-titer shot.

Vaccine researchers were unwilling to abandon their deadly Edmonston-Zagreb high-titer measles vaccine. Instead, they set up a study base in Los Angeles, California. In 1990, three years after the Senegal study was initiated, the first american Black and Hispanic babies were injected with EZ-HT. [Awadu, KO. Outrage! How Babies Were Used as Guinea Pigs in an L.A. County Vaccines Experiment. (Long Beach, CA: Conscious Rasta Press, 1996)]

Even though the WHO and the CDC knew about the high mortality rate already being associated with the vaccine, they still considered the data “preliminary.”

From 1989 to 1991, Kaiser Permanente along with the L.A. County Department of Health and the CDC, injected over 700 “mostly minority” babies with unlicensed experimental vaccines with fraudulently-obtained consent from the parents. Until Los Angeles county, this killer vaccine had only been used in the “Third World.”

Before the trials finished, nearly 1500 minority babies had been given the experimental vaccine, according to this 1996 LA Times article:

”A mistake was made,” said Dr. David Satcher, director of the Atlanta-based federal Centers for Disease Control and Prevention, one of the study sponsors. “It shocked me.” Satcher said in an interview that the CDC plans to contact all the families involved. He said he was very concerned that the events not fuel suspicion in the minority community of government-sponsored medical research.

We now know that the CDC lied about the study on numerous occasions.

1  The “informed consent” form provided to parents violated internationally accepted ethical codes of conduct regulating human experimentation. Parents were not informed that EZ-HT was unlicensed in the US.

2  Parents were told that millions of doses of EZ-HT had been used in Europe. But the LA babies were actually receiving a vaccine that was up to 500 times more potent.

3  The CDC said the communities targeted for the vaccine were those hit hardest by recent measles outbreaks. According to data obtained from the Los Angeles County Department of Health, these communities were not the hardest hit. Journalist Keidi Obi Awadu, in his Outrage!, documented that “three three regions chosen to receive the experimental shots were predominantly Black and Hispanic.” Furthermore, “several mixed-race and White communities harder hit by the recent outbreak of measles were not chosen to participate in the study.”

4  Although the CDC claimed no children were adversely affected, one baby did die from a rare bacterial disease. According to Awadu, several children “experienced what parents are describing as long-term immune system impairment, seizures and other acute conditions consistent with vaccine-induced injury.”

5  Stephen Hadler of the CDC claimed the babies died in earlier studies because they didn't have access to adequate health care. However, one of the more important findings of the Senegal study was “the three vaccine groups were comparable as regards various social, family, and health characteristics. Intensive medical care was provided during the project.”

In 1990, WHO requested 250 million doses of the deadly EZ-HT measles vaccine to be dispensed throughout the world. However, data from Guinea-Bissau, Senegal, and Haiti continued to confirm that EZ-HT doesn't save lives—it increases mortality. By June of 1992, the link was irrefutable; WHO called for a moratorium on use of the disputed vaccine. By some estimates, this may have prevented 18 million baby deaths. [Awadu]